Compounds That Target RIPK4

receptor interacting serine/threonine kinase 4 · 15 compounds in BiohacksAI corpus

RIPK4 (receptor interacting serine/threonine kinase 4) is a biological target with 15 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into RIPK4 modulation for therapeutic and biohacking applications.

View RIPK4 target page →UniProt: P57078 ↗

Most Studied Compounds for RIPK4

Axitinib

298+

studies

Crizotinib

298+

studies

All 15 Compounds — Ranked by Evidence

Erlotinib

5.55

confidence

Foretinib

4.34

confidence

Tozasertib

4.33

confidence

Vandetanib

4.30

confidence

Ruxolitinib

4.23

confidence

Nintedanib

3.61

confidence

Tae 684

3.43

confidence

Fedratinib

3.40

confidence

Lestaurtinib

3.04

confidence

R 406

2.83

confidence

Kw 2449

2.64

confidence

Ast 487

2.56

confidence

Tg100 115

2.08

confidence

Axitinib

298+

studies

0.69

confidence

Crizotinib

298+

studies

0.69

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for RIPK4 (receptor interacting serine/threonine kinase 4). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: RIPK4 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.